Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study
Cardiorenal Medicine · 2024
DOI: 10.1159/000537710 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Kajohnsak Noppakun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Acute Kidney Injury, Coronary Angiography, Contrast Media, Percutaneous Coronary Intervention. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The role of curcuminoids, a striking antioxidant, in prevention of contrast-induced acute kidney injury (CI-AKI) remains unknown. We aim to evaluate the efficacy and safety of curcuminoids in preventing CI-AKI in patients undergoing elective coronary angiography (CAG) and/or percutaneous coronary intervention (PCI).
Methods
We randomized 114 patients who were undergoing elective CAG and/or PCI to receive curcuminoids, 4 grams/day (1 day before, and 1 day after the procedure, n=56) or placebo (n=58). Serum creatinine was assessed at baseline, 12, 24 and 48 hours after contrast exposure. The primary endpoint was development of CI-AKI defined as serum creatinine increase ≥0.3 mg/dL within 48 hours after contrast exposure. The secondary endpoint was the occurrence of kidney injury defined by >30% increase in urine neutrophil gelatinase-associated lipocalin (NGAL).
Results
Baseline characteristics were comparable between the two groups. Seven (12.7%) in curcuminoids group and eight (14.0%) in placebo group developed CI-AKI (p=0.84). The incidence of increased urine NGAL was comparable in the placebo and curcuminoids groups (39.6% vs. 50%, respectively; p=0.34). None in both groups had drug-related adverse events.
Conclusion
This is a pilot study to demonstrate the safety and tolerability of curcuminoids in patients undergoing elective CAG and/or PCI. Curcuminoids have no protective effects against kidney injury after elective CAG and/or PCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
- Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
- Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Zitieren
APA
Noppakun, K., Jitraknatee, J., Suteeka, Y., Ruengorn, C., Nochaiwong, S., Gunaparn, S., Phrommintikul, A., & Wongcharoen, W. (2024). Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study. Cardiorenal Medicine. https://doi.org/10.1159/000537710
Vancouver
Noppakun K, Jitraknatee J, Suteeka Y, Ruengorn C, Nochaiwong S, Gunaparn S, et al. Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study. Cardiorenal Medicine. 2024. doi:10.1159/000537710
BibTeX
@article{Noppakun2024,
author = {Noppakun, Kajohnsak and Jitraknatee, Janjira and Suteeka, Yuttitham and Ruengorn, Chidchanok and Nochaiwong, Surapon and Gunaparn, Siriluck and Phrommintikul, Arintaya and Wongcharoen, Wanwarang},
title = {Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study},
journal = {Cardiorenal Medicine},
year = {2024},
doi = {10.1159/000537710}
}
EUVIMED